Compassionate Use Program for Odronextamab

Sponsor: Regeneron Pharmaceuticals

Expanded Access

Sponsor score: 60

Inactive

ClinicalTrials ID:NCT05619367

This program offers compassionate access to the drug odronextamab for patients who may benefit from it but cannot participate in clinical trials.

Patient Parameters

Parameter	Options

Program Overview

The compassionate use program is designed to provide access to odronextamab, a medication that may help patients who are not eligible for clinical trials. This program aims to offer treatment options for individuals with specific medical needs that cannot be met through standard treatments or ongoing studies.

Eligibility Criteria

Get This Program In Your Inbox

Receive detailed information about this treatment opportunity to review with your healthcare provider.